4-methylcatechol

Known as: 3,4-dihydroxytoluene 
 

Topic mentions per year

Topic mentions per year

1966-2017
05101519662017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
To generate an experimental neuropathy model in which small-diameter sensory nerves are specifically affected and to test a… (More)
  • figure 2
  • figure 1
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2006
2006
Several lines of evidence suggest that rutin, flavonoid in fruits and vegetables, or one of its metabolites may effectively… (More)
Is this relevant?
2004
2004
Catechol 2,3-dioxygenase (C23O; EC 1.3.11.2), exemplified by XylE and NahH, catalyzes the ring cleavage of catechol and some… (More)
Is this relevant?
2004
2004
Toluene-o-xylene monooxygenase (ToMO) from Pseudomonas stutzeri OX1 oxidizes toluene to 3- and 4-methylcatechol and oxidizes… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2003
2003
Assessment of the in vitro cytotoxicity has recently been become popular as a primary screening method for evaluating the… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2001
2001
Sensory neuropathies are frequently associated with diabetes or with antimitotic treatments in humans suffering from cancer, and… (More)
Is this relevant?
1999
1999
Practical use of brain-derived neurotrophic factor (BDNF) as therapy is limited by two serious problems, i.e., its inability to… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 5
Is this relevant?
1996
1996
Acrylamide (ACR) monomer produces neuropathy of the dying-back type and 4-methylcatechol (4-MC) is a potent stimulator of… (More)
Is this relevant?
1995
1995
The effect on peripheral nerve regeneration of 4-methylcatechol (MC), which is a potent inducer of nerve growth factor (NGF… (More)
Is this relevant?
1994
1994
The carcinogenic potentials of 4-methoxyphenol (4-MP) and 4-methylcatechol (4-MC), phenolic compounds which are structurally… (More)
Is this relevant?